Anemia drug dispute fills CMS mailbag. (Medicare Pass-Through).(Centers for Medicare and Medicaid Services)(Brief Article)

Publication: Medicine & Health

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2003 Eli Research, Inc.

Both Republicans and Democrats are criticizing the way the Centers for Medicare and Medicaid Services determines which outpatient drugs are eligible for extra payments designed to encourage the use of new technologies while their costs are being incorporated into the appropriate hospital outpatient prospective payment system reimbursement category.

In...

Read the full article for free courtesy of your local library.